Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Plexin A2 ELISA Kit (AC2515)
Cat.#: ASET-1104
Specifications
Description Human Plexin A2 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Plexin A2 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.027 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.25-20 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1666 Porcine Ghrelin ELISA Kit (AC3077) Quantitative inquiry ASET-1565 Human BASP1 ELISA Kit (AC2976) Quantitative inquiry ASET-1477 Mouse CaMKII beta ELISA Kit (AC2888) Quantitative inquiry ASET-2017 Mouse Somatostatin ELISA Kit (AC3428) Quantitative inquiry ASET-1989 Mouse FGF2 ELISA Kit (AC3400) Quantitative inquiry ASET-2045 Human MRP8 ELISA Kit (AC3456) Quantitative inquiry ASET-1637 Human PPAR gamma ELISA Kit (AC3048) Quantitative inquiry ASET-1674 Mouse Angiogenin ELISA Kit (AC3085) Quantitative inquiry ASET-1168 Human Otx2 ELISA Kit (AC2579) Quantitative inquiry ASET-1511 Rat TIMP3 ELISA Kit (AC2922) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket